Making cholestyramine palatable
Thompson, W.G.
Canadian Medical Association Journal 104(11): 986
1971
ISSN/ISBN: 0008-4409 PMID: 5576046 Document Number: 37244
Document emailed within 1 workday
Related Documents
1997: Can we make low-fat foods more palatable? Oncology 11(8): 1100Finan, T.J.; Nelson, D.R. 2001: Making rain, making roads, making do: Public and private adaptations to drought in Ceara, Northeast Brazil Climate Research 19(2): 97-108
Tweed, M.; Wilkinson, T. 2019: Student progress decision-making in programmatic assessment: can we extrapolate from clinical decision-making and jury decision-making? Bmc Medical Education 19(1): 176
Hecht, Y. 1978: Cholestyramine in hepatology Medecine and Chirurgie Digestives 7(8): 705-708
Tashev, T.; Brailski, K.; Braikova, N.; Mendizova, A.; Adzharov, D. 1974: Treatment of cholestasis with cholestyramine Vutreshni Bolesti 13(1): 60-65
Poley, J.R. 1978: Cholestyramine and intestinal obstruction Pediatrics 61(2): 332
Schade, R.W.; Laar A van't; Jansen, A.P. 1973: Treatment of type Ii hyperlipoproteinaemia with cholestyramine Netherlands Journal of Medicine 16(6): 254-259
Audétat, V.; Paumgartner, G.; Bircher, J. 1977: Does cholestyramine impair the bioavailability of prednisolone? Schweizerische Medizinische Wochenschrift 107(15): 527-528
Acuña, R.; González Ceron, M. 1977: Hypoprothrombinemia and bleeding associated to treatment with cholestyramine Revista Medica de Chile 105(1): 27-28
Reddy, C.M.; Hara, S.; Crump, E.P. 1977: Cholestyramine treatment of intractable diarrhea Journal of the Tennessee Medical Association 70(9): 643; 61
Trülzsch, D.; Amler, G.; Mohr, G.; Richter, E. 1975: Drug metabolism during cholestyramine administration in the rat Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1656-1659
Belamarich, P.F.; Deckelbaum, R.J.; Starc, T.J.; Dobrin, B.E.; Tint, G.S.; Salen, G. 1990: Response to diet and cholestyramine in a patient with sitosterolemia Pediatrics 86(6): 977-981
Loginov, A.S.; Iartseva, A.M.; Kriukova, L.V. 1973: Cholestyramine treatment of patients with intrahepatic cholestasis Sovetskaia Meditsina 36(8): 90-94
Coltman, D.; Mann, M.D.; Bowie, M.D. 1990: Effect of cholestyramine on activity of gentamicin in vitro Pediatrics 85(3): 390-391
Jones, R.J.; Dobrilovic, L. 1970: Lipoprotein lipid alterations with cholestyramine administration Journal of Laboratory and Clinical Medicine 75(6): 953-966
Renting, N. 2018: Direct observation in postgraduate training: making it happen and making it work Medical Education 52(12): 1218-1220
Kapol, N.; Maitreemit, P.; Chalongsuk, R.; Amrumpai, Y.; Sribundit, N.; Thavorncharoensap, M.; Chaikledkaew, U.; Teerawattananon, Y. 2008: Making health technology assessment information available for decision making: the development of a Thai database Journal of the Medical Association of Thailand 91(Suppl 2): S8-10
Vygovskiĭ, V.P.; Proniv, L.N. 1987: Use of cholestyramine by patients with chronic ischemic heart disease Vrachebnoe Delo 2: 77-79
Coello-Ramírez, P. 1977: Cholestyramine in a case of a prolonged diarrhea after a partial ileocolectomy Boletin Medico del Hospital Infantil de Mexico 34(2): 325-328
Suárez-Otero, R.; Robles-San Román, M.; Jaimes-Hernández, J.; Oropeza-De La Madrid, E.; Medina-Peñaloza, R.M.; Rosas-Ramos, R.; Castañeda-Hernández, G. 2002: Efficacy and safety of diclofenac-cholestyramine and celecoxib in osteoarthritis Proceedings of the Western Pharmacology Society 45: 26-28